These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17373991)

  • 1. Treatment of alopecia areata with sulfasalazine.
    Misery L; Sannier K; Chastaing M; Le Gallic G
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):547-8. PubMed ID: 17373991
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a role for sulfasalazine in the treatment of alopecia areata?
    Bakar O; Gurbuz O
    J Am Acad Dermatol; 2007 Oct; 57(4):703-6. PubMed ID: 17610992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows.
    Faghihi G; Andalib F; Asilian A
    Eur J Dermatol; 2009; 19(6):586-7. PubMed ID: 19620039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfasalazine for alopecia areata.
    Ellis CN; Brown MF; Voorhees JJ
    J Am Acad Dermatol; 2002 Apr; 46(4):541-4. PubMed ID: 11907504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata.
    Ochoa BE; Sah D; Wang G; Stamper R; Price VH
    J Am Acad Dermatol; 2009 Sep; 61(3):530-2. PubMed ID: 19700021
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
    Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
    J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of persistent alopecia areata with sulfasalazine.
    Rashidi T; Mahd AA
    Int J Dermatol; 2008 Aug; 47(8):850-2. PubMed ID: 18717871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
    Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
    Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia areata during etanercept therapy.
    Pan Y; Rao NA
    Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of alopecia areata by topical diclofenac sodium gel in comparison to benzoyl peroxide gel. A novel single blind therapeutic clinical trial.
    Sharquie KE; Al-Nuaimy AA; Kadhum WJ
    Saudi Med J; 2006 Jul; 27(7):1079-81. PubMed ID: 16830041
    [No Abstract]   [Full Text] [Related]  

  • 11. [Methods of treating alopecia areata].
    Kozłowska A
    Przegl Dermatol; 1987; 74(2):156-61. PubMed ID: 3313534
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful use of bimatoprost in the treatment of alopecia of the eyelashes.
    Zaheri S; Hughes B
    Clin Exp Dermatol; 2010 Jun; 35(4):e161-2. PubMed ID: 19925481
    [No Abstract]   [Full Text] [Related]  

  • 13. An immunologic mechanism for the therapeutic efficacy of minoxidil in alopecia areata.
    Namazi MR; Handjani F
    J Drugs Dermatol; 2004; 3(2):129-30. PubMed ID: 15098965
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of insulin-like growth factor-I by cepharanthine from dermal papilla cells: a novel potential pathway for hair growth stimulation.
    Inui S; Itami S
    J Dermatol; 2013 Dec; 40(12):1054-5. PubMed ID: 24164396
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alopecia areata: update on therapy].
    Assouly P
    Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):831-6. PubMed ID: 12223967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the therapeutic effect of DNBC-induced contact dermatitis in alopecia areata].
    Broniarczyk-Dyła G; Omulecki A
    Przegl Dermatol; 1983; 70(5-6):557-61. PubMed ID: 6366925
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of response of alopecia areata to pimecrolimus cream.
    Rigopoulos D; Gregoriou S; Korfitis C; Gintzou C; Vergou T; Katrinaki A; Kalogeromitros D
    Clin Exp Dermatol; 2007 Jul; 32(4):456-7. PubMed ID: 17537231
    [No Abstract]   [Full Text] [Related]  

  • 18. An uncontrolled, open label study of sulfasalazine in severe alopecia areata.
    Aghaei S
    Indian J Dermatol Venereol Leprol; 2008; 74(6):611-3. PubMed ID: 19171984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How far should treatment of severe alopecia areata be managed?].
    Delaporte E
    Ann Dermatol Venereol; 1996; 123(2):139-42. PubMed ID: 8761773
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral administration of cyclosporin A in patients with severe alopecia areata.
    Rallis E; Nasiopoulou A; Kouskoukis C; Roussaki-Schulze A; Koumantaki E; Karpouzis A; Arvanitis A
    Int J Tissue React; 2005; 27(3):107-10. PubMed ID: 16372476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.